Develo Raises $14M Series A
AI-native operating system for independent pediatric practices. Led by Blueprint Equity with participation from Villain Capital, Z21 Ventures, and Bienville Capital.
$14M
Series A
May 11, 2026
Blueprint Equity
Villain Capital, Z21 Ventures, Bienville Capital
Los Angeles, CA
The Deal
Develo announced a $14M Series A on May 11, 2026, led by Blueprint Equity with participation from Villain Capital, Z21 Ventures, and Bienville Capital. The Los Angeles company sells an AI-native operating system for independent pediatric practices that combines EMR, billing, and family-engagement workflows into a single platform. The company said the new capital will support growth, R&D, and customer success. At the time of the announcement, Develo said its platform was deployed across hundreds of pediatric providers in more than two dozen states.
Context
This is a notable bet on pediatric practice infrastructure rather than care delivery. Most pediatric software still sits on adult-first EMRs or legacy pediatric systems with fragmented intake, billing, and family-communication layers, so Develo is positioning around workflow unification and pediatrics-specific AI rather than another virtual-care front end. That makes the round relevant to the independent-practice layer, where margin pressure, staffing shortages, adolescent-privacy requirements, and Medicaid-heavy reimbursement make operational software quality unusually consequential.